About Us

Xiamen Biotime Biotechnology Co., Ltd.
About Biotime Established in April 2008, Xiamen Biotime is a hi-tech enterprise that specialized in R&D, production, and sales of POCT in vitro diagnostic devices and reagents. Biotime has successfully established the mature medical marketing channels during the past years. With the leading technologies, Biotime aims to develop superior IVD products that provide better solutions for health care and benefit people all over the world.  Our Vision Become a leading POCT enterprise Our Mission Make science and technology serve health Our Technology Platforms Biotime has developed “Eight Technology Platforms” which includes the colloidal gold, fluorescence immunoassay, electrochemistry, High-performance liquid chromatography, raw materialdry biochemistry, molecular diagnostics and chemiluminescence. Our Team 7+ Global R&D Centers (Singapore, the United States, Shenzhen, Shanghai, Chongqing, Hangzhou, Xiamen) 9+ Products are the global pioneer in fluorescent immuassay solution 30+ Core intellectual property rights 20+ Years of industry experience of engineers 200+ Engineers 800+ Globalwise distributors Our Business Biotime always take actively respond to the market demand for testing products and we are proud to work with a network of collaborators in over 50 countries. Our Journey Certifications 100+ certifications including FDA(EUA), CE, ISO 13485, NGSP, Russia
2008
20082008
 Since
2000
20002008
+
Employees                                                                              
110
1102008
+
Countries                                                                   
100
1002008
+
Certificates                                               
Hot Products
 
View All Products
Our Technologies
Light-initiated Chemiluminescence Assay (LiCA)
01
Light-initiated Chemiluminescence Assay (LiCA)
Light-initiated Chemiluminescence Assay (LICA) is derived from the luminescent oxygen channeling immunoassay (LOCI) with the desired features. Similar to the principle of LOCI, LICA is a homogenous bead-based technology in which the proximity of chemo beads and sensible ads (< 200 nm) generates light through CL. This homogeneous immunoassay method is capable of rapid, quantitative determination of a wide range of analytes--including high and very low concentrations of large and small molecules, free (unbound) drugs, DNA, and specific IgM. Light-initiated Chemiluminescence Assay is one of the emerging formats of immunoassay. More and more manufacturers set off to develop new products based on this new and innovative emerging technology because there are plenty of benefits of using it which include: Homogeneous High sensitivity High specificity High throughput Reproducibility Wide detection range Low sample volume Doesn’t require a washing step
Immunofluorescence Platform
02
Immunofluorescence Platform
Immunochromatography is also called immunoaffinity chromatography. The specific processes are as follows: a specific antibody containing the marker is dropped on the bonding pad, and a specific antibody is added at a location of the nitrocellulose membrane. After the sample liquid of the sample to be tested is added to the sample pad, through the action of the capillary tube, the sample solution and the marker are uniformly diffused at the binding pad through the action of the capillary tube. The sample solution reacts with the europium chelate to form the complex of the europium antibody chelate. The complex containing the europium antibody chelate then flows forward. When the complex moves to the detection band, because the detection band contains a specific antibody, it has a specific immune reaction with the europium antibody chelate-containing antigen and finally forms the immune complex of antigen-antibody-europium antibody complex. At the same time, the labeled antibody was also captured on the test line and stayed in the test line, while the redundant markers continued to flow forward and were adsorbed to the control band by the protein antibody on the membrane, and the complex specific binding occurred on the control line, and at the same time, the labeled antibody was also captured on the control line. According to the difference of marker types, the signal is detected by the instrument.
HPLC
03
HPLC
HbA1c can be measured by different methods. But high performance liquid chromatographic (HPLC) methods are considered as a gold standard method for measuring HbA1c in human blood. A chemical (electrical) charge is present on the molecule of HbA1c, and the amount of the charge differs from the charges on the different components of hemoglobin. The molecule of HbA1c has a difference in size from the other components. HbA1c may be separated by charge and size from the other hemoglobin A components in blood by HPLC. HPLC separates mixtures into their various components by adding the mixtures to special liquids and them under pressure through columns filled with a material that separates the mixture into its different component molecules.
Contact Us
 
  • Address

    5F No. 188, Pingcheng South Road, Haicang Street, Haicang District, Xiamen, Fujian, 361026, P. R. China

  • Company

    Xiamen Biotime Biotechnology Co., Ltd.

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact